VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Did we need a Halt for that?

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Sep 27, 2021 9:17pm

192 Views

Post# 33928717

RE:Did we need a Halt for that?

Theblessed1 wrote: Seriously and minutes before market close 3:36 PM?

Just release the news post market.

I give Dr. Adams lots of credit for what he has done in past.
But
Sorry but this is amateurish.

I see VMC put out a $10M financing less than an hour after VPT and they did not use a halt.
It was for a debenture and not common stock - if that makes a difference?

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale